About Andrew

Dr Andrew Hill graduated from Oxford University, and then worked on HIV at St Mary's Hospital in London. He has a PhD from the University of Amsterdam. He is a Senior Visiting Research Fellow at Liverpool University in the UK, specialising in treatment access issues. His research team works on the costs of production of drugs to treat HIV, viral hepatitis, TB and cancer. He also works as an advisor to the World Health Organisation, UNITAID and the Clinton Foundation.

This speaker will be presenting at the following session(s)

  • Access to hepatitis medicines

    Golden Hall

    Day: 2 November

    Time: 11:15

    This panel session examines the key barriers and current strategies to scale up access to hepatitis treatment.

    Chair: Dr. Jackson Amone, Ministry of Health, Uganda

    Presentations:

    • Generic DAAs; where they are and for how much.
    • Giten Khwairakpam, amfAR
    • What price for what drug: is there a science to it?
    • Dr. Andrew Hill, Liverpool University, UK
    • Options for treatment access in countries with and without access to generics and role of different actors (including new WHO estimates of hepatitis treatment access).
    • Dr. Yvan Hutin, World Health Organization

    Objectives:

    • To review different approaches to overcoming access barriers and the progress made.